US Rheumatologists Reluctant to Switch to Biosimilars for Patients Doing Well on a Reference Product

November 16th 2020, 3:00pm


Although half of US rheumatologists have patients for which nonmedical switching has been suggested, only 35% were likely to switch patients with rheumatoid arthritis doing well on a reference product to a biosimilar.

Telemedicine Improved Appointment Adherence for Rheumatology Visits

November 11th 2020, 1:00pm


Improvements in completed visits while using telemedicine to conduct rheumatology visits during the coronavirus disease 2019 pandemic may present an option for continued telemedicine use for follow-up care.

Black Patients With RA Less Likely Than White Counterparts to Be Prescribed a Biologic

November 9th 2020, 1:00pm


The study also found that Black patients with rheumatoid arthritis (RA) are more likely to be prescribed glucocorticoids, which come with a risk of serious long-term adverse effects.

Data Show Novartis’ Secukinumab Leads to Early Synovitis Reduction in Patients With PsA

November 5th 2020, 10:00pm


New results from the phase 3 ULTIMATE trial show Novartis’ Cosentyx (secukinumab) demonstrated significant treatment response on synovitis in patients with active psoriatic arthritis (PsA) compared with placebo.

Patients With Rheumatic Diseases at No Greater Risk of Contracting COVID-19

November 4th 2020, 10:29pm


Despite concerns about treatment with immunosuppressive agents, coronavirus disease 2019 (COVID-19) infection remains low in patients with rheumatic diseases, according to 2 abstracts presented at the annual meeting of the American College of Rheumatology.

11 Groups Join ACR in Opposition of UHC’s “Disastrous” Co-Pay Policy

October 30th 2020, 9:30pm


The American College of Rheumatology (ACR) has joined forces with other provider groups to oppose a plan proposed by UnitedHealthcare that would increase patients’ out-of-pocket costs.

Enthesitis in Psoriatic Arthritis Increases Disease Burden, Decreases Treatment Satisfaction

October 27th 2020, 9:45pm


Patients with psoriatic arthritis with enthesitis are more likely to have severe disease than patients without enthesitis, and they and their physicians are less likely to be satisfied with their treatments.

Interruptions to In-Person Visits During Pandemic Did Not Negatively Impact Patients With Inflammatory Arthritis

October 24th 2020, 2:00pm


In the first wave of the coronavirus disease 2019 pandemic, patients with axial spondyloarthritis, rheumatoid arthritis, and psoriatic arthritis didn’t have an increase in disease activity despite an interruption in in-person interactions.

Prescribing Patterns for Second-Line Treatment of Rheumatoid Arthritis

October 23rd 2020, 8:35pm


Despite the benefits of switching to a different mode of action in the second line, almost half of patients with rheumatoid arthritis were cycled to a second tumor necrosis factor inhibitor.

Identifying Patients With Psoriatic Arthritis Who Need Cardiovascular Risk Factor Interventions

October 16th 2020, 9:30pm


Using the Framingham risk score to differentiate patients with psoriatic arthritis with and without coronary artery disease can underestimate cardiovascular risks in these patients.